Stemline Therapeutics' Series A Round

Stemline Therapeutics raised a round of funding on April 15, 2008. Investors include Pequot Capital Mangement.

Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology therapeutics that target cancer stem cells (CSCs) as well as the tumor bulk. Among Stemline's drug candidates ar…

Articles about Stemline Therapeutics' Series A Round: